» Authors » Marcelo Basso Gazzana

Marcelo Basso Gazzana

Explore the profile of Marcelo Basso Gazzana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 514
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorenzi W, Wainstein R, Rodrigues R, Benedetto I, Gazzana M
J Bras Pneumol . 2025 Jan; 50(6):e20240231. PMID: 39813499
No abstract available.
2.
de Barros E Silva P, Furtado R, de Alcantara Chaud M, Macedo A, Bronhara B, Damiani L, et al.
J Thromb Thrombolysis . 2024 May; 57(6):1031-1039. PMID: 38762708
Therapeutic anticoagulation showed inconsistent results in hospitalized patients with COVID-19 and selection of the best patients to use this strategy still a challenge balancing the risk of thrombotic and hemorrhagic...
3.
Benedetto I, Silva R, Hetzel G, Viana G, Guimaraes A, Folador L, et al.
J Bras Pneumol . 2023 May; 49(3):e20220452. PMID: 37255163
Objective: To investigate the impact of impaired pulmonary function on patient-centered outcomes after hospital discharge due to severe COVID-19 in patients without preexisting respiratory disease. Methods: This is an ongoing...
4.
Viana M, Pellegrini J, Perez A, Schwarz P, da Silva D, Teixeira C, et al.
Crit Care . 2023 Apr; 27(1):143. PMID: 37061719
Background: Previous studies have demonstrated a beneficial effect of early use of corticosteroids in patients with COVID-19. This study aimed to compare hospitalized patients with COVID-19 who received short-course corticosteroid...
5.
Spilimbergo F, Rodrigues R, Credidio Dias-Pinto M, Blanco D, Barbieri G, Andrade-Lima M, et al.
Pulm Circ . 2023 Mar; 13(1):e12193. PMID: 36968814
Pulmonary arterial hypertension (PAH) is a severe and progressive disease characterized by increased pulmonary vascular resistance, ultimately leading to right heart failure and death. Registries are a valuable tool in...
6.
Fernandes C, Ota-Arakaki J, Campos F, Correa R, Gazzana M, Jardim C, et al.
J Bras Pneumol . 2022 Jun; 46(4):e20200204. PMID: 35766678
Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious and debilitating disease caused by occlusion of the pulmonary arterial bed by hematic emboli and by the resulting fibrous material. Such occlusion...
7.
Lopes R, de Barros E Silva P, Furtado R, Macedo A, Bronhara B, Damiani L, et al.
Lancet . 2021 Jun; 397(10291):2253-2263. PMID: 34097856
Background: COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is unknown. We aimed to compare the...
8.
Rosa R, Robinson C, Veiga V, Biasi Cavalcanti A, de Azevedo L, Machado F, et al.
Rev Bras Ter Intensiva . 2021 Apr; 33(1):31-37. PMID: 33886851
Introduction: The long-term effects caused by COVID-19 are unknown. The present study aims to assess factors associated with health-related quality of life and long-term outcomes among survivors of hospitalization for...
9.
Cortozi Berton D, Mendes N, Olivo-Neto P, Benedetto I, Gazzana M
J Bras Pneumol . 2021 Feb; 47(1):e20200406. PMID: 33567064
Chronic unexplained dyspnea and exercise intolerance represent common, distressing symptoms in outpatients. Clinical history taking and physical examination are the mainstays for diagnostic evaluation. However, the cause of dyspnea may...
10.
Piltcher-DA-Silva R, Chedid M, Grezzana Filho T, Leipnitz I, de Araujo A, Gazzana M, et al.
Int J Artif Organs . 2021 Jan; 45(1):121-123. PMID: 33478326
Hepatopulmonary syndrome (HPS) is a complication of end stage liver disease (ESLD) and is manifested by severe hypoxemia, which usually responds to liver transplantation (LT). As compared to patients undergoing...